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Pigmentation defects are common in the inherited disease 
type 1 neurofibromatosis (NFl), predicting a role for the 
NFl gene product, neurofibromin, in the skin. We used 
immunohistochemistry to determine the distribution of 
neurofibromin in normal developing and adult rat skin, nor-
mal neonatal and adult human skin, and skin from patients 
affected with NFL The distribution of NFl mRNA in the 
epidermis was also analyzed by in situ hybridization. NI:1 
mRNA and neurofibromin are highly enriched in the kerati-
nocytes in the stratum spinosum of the epidermis in the em-
bryonic, but not adult, rat and in both neonatal and adult 
humans. Immunoelectron microscopic analysis confirmed 
T ype 1 neurofibromatosis (NFl) is an autosomal domi-nantly inherited disorder affecting one in 3500 indi-viduals worldwide [1,2] caused by mutation at the NF1 locus. Individuals with NF1 typically develop multiple hyperpigmented patches of skin called cafe-
au-lait macules (CALM) as well as lisch nodules, and dermal, subcu-
taneous, and plexiform neurofibromas [3] . The presence of six or 
more CALM larger than 5 mm in the prepubertal child is one of the 
diagnostic criteria for NFl [1]. CALM appear in the first year of life 
in 80% of individuals with NFl, and are present by 4 years of age in 
all affected children [4] . 
Neurofibromin, the protein product of the NFl gene, is a 220-
280 kD protein [5 - 9]. The distribution of neurofibrornin in the 
skin of humans, with or without NFl, has not been studied. The 
prevalence of abnormalities in pigmentation in NFl patients pre-
dicts that one or more of the cell types in the skin should express 
neurofibromin. Melanocytes in CALM have abnormally large, ir-
regular pigment granules (macromelanosomes) [10-15]. Lisch 
nodules consist of discrete masses of melanocytes [16]. Based on 
these data and the frequency ofSchwann cell tumors in NFl, it has 
been proposed that NF 1 involves a primary defect of the neural crest 
cell lineage [16]. However, in the nervous system, although neural 
crest - derived Schwann cells express neurofibromin, non - crest-
derived cells such as neurons and oligodendrocytes also express 
neurofibromin [5,17,18]. We previously developed antibodies that 
recognize neurofibromin and showed that neurofibromin is not 
detectable in adult rat skin [5,17], but is detectable in embryonic day 
16 rat skin [5]. We have now used these reagents to determine if the 
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that neurofibromin is associated with the keratinocyte 
plasma membrane, particularly adjacent to desmosomes. 
Neurofibromin is also detectable in human melanocytes. 
Analysis of skin from NFl patients showed normal neurofi-
bromin expression in nine of ten hyperpigmented cafe-au-
lait macules and in adjacent unaffected skin. We conclude 
that 1) neurofibrornin expression in the perinatal rat closely 
parallels expression in the human; 2) reduction in detectable 
neurofibromin cannot be used to distinguish NFl and nor-
mal human skin; and 3) neurofibromin might function in 
keratinocytes, as well as melanocytes. Key words: NF1/Ras/ 
desmosome/membrane.] Invest DermatoI102:812-818, 1994 
neural crest-derived cells of the epidermis, melanocytes, express 
neurofibromin and/or if non-neural crest-derived cells in the epi-
dermis express neurofibromin. 
Neurofibromin has been detected in different subcellular com-
partments in different cell types. In b-lymphocytes neurofibromin 
was detected at the plasma membrane [19]; in neurons neurofibro-
min is present in smooth endoplasmic reticulum [18], and in fibro-
blasts with microtubules [8] or organelles associated with microtu-
buies [7]. Cloning and sequencing of the NF1 gene revealed 
sequence homology to GTPase activating proteins (GAPs) [20 - 22], 
which act as negative regulators of the protooncogene product Ras 
by facilitating the GTPase activity of Ras subsequent to growth or 
differentiation signals [23,24]. GAP-like enzymatic activity has 
been demonstrated for neurofibromin [7,21,22 - 25]. As Ras is 
thought to act at the plasma membrane [26]. if neurofibromin inter-
acts with Ras neurofibromin should also be detectable at the plasma 
membrane. Therefore, we defined the subcellular location of neur-
ofibromin in cells of the epidermis. 
Here, we show that in the skin neurofibromin is expressed by 
neural crest-derived melanocytes, and also by keratinocytes. In 
keratinocytes, neurofibromin is present at the plasma membrane, 
consistent with the hypothesis that neurofibromin might interact 
with Ras. No obvious alterations in neurofibromin distribution 
were evident in nine of ten CALM from NFl patients, whereas one 
of ten showed absence of neurofibromin in keratinocytes but not 
melanocytes. 
MATERIALS AND METHODS 
Tissue Preparation Adult, postnatal day 6 (P6) and P2 [timed-pregnant 
Sprague-Dawley rats were obtained through the supplier (Zivic- Miller) 
with EO being the morning the copulatory plug was observed] were anesthe-
sized and intracardially perfused with fixative as described [17]. Adult rat 
skin was taken from behind the ear; P2 and P6 rats were decapitated. Em-
bryos were dissected from timed-pregnant rats and decapitated. Embryonic 
day 15 (EI5), E19, E21, P2 and P6 rat heads, adult rat skin, adult human skin, 
and neonatal foreskin samples were all fixed in perfusion fixative at 4 0 C for 
24 h, cryoprotected, and cryostat sections (10/lm) cut. 
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F~gure~. Dist.ribution of ne~rofi?romin i~ deve!oping rat.epidermis. Cryostat sections of rats a~es E19 (A), E21 (B), P2 (C), and P6 (D) were immunos-
tamed wIth antl-neuro~bromtn usmg peroxIdase nnmunohlstochemlstry. A -~) Neurofibromm IS expressed predominantly in the differentiating keratino-
cytes of the stratum sptnosum and granulosum (flared arrows). Kerattnocytes tn the stratum germtnatum (black arrowheads) are less intensely stained and 
keratinocytes in the stratum corneum (opet/ arrowheads) are unstained. Scale bar, 20 pm. 
ImD1unohistochemistry Immunohistochemistry was performed as de-
scribed [17]; peroxidase staining was visualized by HRP methods using the 
Vectastain Elite kit (Vector Labs, Burlingame, CAl. Fluorescence double 
labeling was performed by incubating blocked sections for 2 h at room 
temperature and then overnight at 4' C with a monoclonal anti-melanocyte 
antibody TA99, which recognizes the gp 75 antigen [27] in phosphate-buf-
fered saline (PBS) containing 1 % bovine serum albumin (BSA). After rins-
ing, sections were incnbated for 90 minu at room temperature with a rhoda-
mine-labeled goat anti-mouse IgG secondary antibody (Organoteknika 
Cappel Biochemicals) (1 :200) in PBS containing 1 % BSA. After rinsing, 
fixation with 4% para formaldehyde and repeat rinsing, sections were re-
blocked for 1 h at room temperature and then immunostained with antin-
eurofibromin as described previously [17]. 
Preparation of NFl Oligonucleotides Two 25-mer oligonucleotides 
were synthesized and gel-purified on an 8% polyacrylamide/6 M urea gel. 
The oligonucleotides were the sense and antisense strand of sequence from 
rat NFl cDNA (by comparison to human sequence in [28]) 3993-4017: 5' 
CCTTGAGGAGAACCAGAGGA ACCTC 3'. Oligonucleotides were la-
beled at the 3' end by terminal deoxynucleotidyltransferase and a_3SS dA TP 
to a specific activity of 1-4 X 10' cpm pg" [29]. 
In Situ Hybridization Protocols for hybridization were essentially as de-
scribed [30]. Sections were incnbated at 37'C for 16-18 h in a moist 
chamber with 1 X 106 cpm of labeled probe in 100/11 of hybridization fluid 
(40% formamide, 0.3 M NaCI, 20 mM tris HCI (PH 8), 5 mM ethylene 
diaminetetraacetic acid (EDTA), 10 mM NaPO. (pH 8), 10% dextran sul-
fate, 1 X Denhardt's solution, 0.5 mg/ml yeast RNA, and 200 mM dithio-
threitol, rinsed four times in 1 X SSC with 1 mM dithiothreitol at 58'C for a 
total of 60 min, then in 1 X SSC with 1 mM dithiothreitol at room tempera-
ture for 1 h. Secttons were dehydrated, dipped in NTB-2 emulsion (Kodak) 
for autoradiography, exposed for 5 to 8 weeks, developed, and visualized 
using darkfield microscopy. 
Immunoelectron microscopy Ultrastmctural analysis was carried out 
as described [18], except that PO rats were perfused with fixative in which the 
glutaraldehyde concentration was increased to 0.8%. 
Human Tissue CALM and adjacent, non-CALM biopsies were obtained 
from nine patients, eight of whom had a family history of NFl; all had 
mnlttple CALM, three had neurofibromas, and rwo had optic glioma. Pres-
ence of Lisch nodules was not ascertained. Patients ranged in age from 9 to 
49. BIOpsy site varied, but included rwo from the anterior thigh. The sec-
tions described in Figs 4 and 5 were from an additional patient; an anterior 
thigh biopsy was taken from a 51-year-old man; NFl diagnosis was based 
on family history, multiple CALM, and multiple cutaneous neurofibromas. 
Con~rol .adult human tissue was obtained on autopsy from three patients 
rangtng III age from 43 to 71 . Normal foreskin was obtained 2 d after birth 
from rwo infants. 
RESULTS 
Specificity of Anti-Neurofibromin Antibodies Affinity-pu-
rified polyclonal antibodies raised against two different domains 
(amino acids 772-1085 and 2435 -2745) (nomenclature according 
to [31]) of human neurofibromin were used to stain tissue sections. 
The specificity of these antibodies has been demonstrated previ-
ously [5,17,18). Both antibodies stained the same cellular elements 
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Figure 2. Ultrastructural 
distribution of epidermal 
neurofibromin in the PO 
rat. Neurofibromin is lo-
calized at the keratinocyte 
plasma membrane ad-
j acent to desmosol11es. 
Pre-embedding electron 
microscopy with anti-
neurofibromin (A, C, D) 
or anti-neurofibromin 
preincubated with cog-
nate fusion protein (B), 
detected with peroxidase-
DAB. Reaction product is 
black. The nucleus (n), 
nuclear envelope (ne), 
mitochondria (m), glyco-
gen (g) , pigment granule 
(pg), filaments (£) , and 
desmosomes (small arrows) 
all appear unstained. 
Larger Jlared arrows, reac-
tion product at plasma 
membrane; ope/J arrow-
heads, intracellular vesicles 
with reaction product. 
Scale bar, 50 nm. 
of the epidermis in both the rat and the human. Staining was abol-
ished when the antibodies were preabsorbed with their appropriate 
fusion protein and was absent when pre-immune sera was applied to 
sections. 
Distribution of Neurofibromin in the Epidermis of the De-
veloping Rat The pattern of neurofibromin expression in the 
developing rat epidermis was analyzed by immunohistochemistry at 
E15, E19, E21, P2, and P6. Neurofibromin was detected in both the 
s. germinatum and the periderm at E15 (not shown; terminology of 
epidermal strata according to [32]) . By E19 (Fig lA), neurofibromin 
staining was robust in cells of the s. spinosum and was notably less 
intense in the s. germinatum and s. granulosum. In preparation for 
birth, rats exhibit marked hyperplasia of the interfollicular epider-
mis and accelerated keratinization and cornification (33)' At E21 
and P2 (Fig IB,C), neurofibromin was expressed most prominently 
in the s. spinosum, less intensely in the s. germinatum and s. granu-
losum and was undetectable in the newly developed s. corneum; 
staining was slightly less intense by P2. Neurofibrornin staining was 
significantly reduced across all strata by P6 (Fig ID) confirming 
results by Western blot analysis [5]. Neurofibromin is not detectable 
in adult rat skin [5,7,17]. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Ultrastructural Localization of Keratinocyte Neurofibro-
min in the Rat The ultrastructural distribution of neurofibromin 
in the rat epidermis was determined by pre-imbedding immunoe-
lectron microscopy in keratinocytes in the s. spinosum of E21 rat 
embryos (Fig 2), as it appeared most enriched in these keratinocytes. 
Reaction product was not visible when antibody was preabsorbed 
with cognate fusion protein prior to application to sections (Fig 2B). 
Peroxidase reaction product was observed at non-desmosome con-
taining regions of the plasma membrane (Fig 2A,C,D) and in vesi-
cles in the cytosol that are likely to be transport vesicles (Fig 2C,D). 
Reaction product was not associated with mitochondria, nuclear 
envelope, filaments, or desmosomes (Fig 2A,C,D). Exclusion from 
desmosomes may be due to failure of antibodies to penetrate these 
protein-dense structures [34] . In many instances, neurofibromin 
immunoreactivity was enriched in patches of plasma membrane of 
adjacent cells where the plasma membranes were apposed (Fig 
2A,D). 
Distribution of NF1 mRNA in the Epidermis of the Embry-
onic Rat To determine which cells of the epidermis synthesize 
neurofibromin, the cellular pattern of NFl mRNA expression was 
analyzed by ill situ hybridization in E21 rat skin, as neurofibromin 
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Figure 3. Neurofibromin mRNA in keratinocytes. Irl sitll hybridization of cryostat sections of rat skin at E2l using a 25-bp synthetic oLigonucleotide sense 
(C) or anti-sense probes (B), ~isualized ~n darkfield microscopy. Adjacent sections were srained with hematoxylin and eosin (A) and visualized ~mder 
brightfield Optics. Neurofibromm mRNA IS observed 111 the stratum sp1l10sum and granulosum usmg the anti-sense probe but not the sense probe. Cells tn the 
basal layer (b) do not have detectable levels of mRNA. Scale bar, 40 lim. 
Figure 4. Epidermal 
distribution of neuro-
fibromin in normal 
human skin and NFl 
CAL macules. Cryo-
stat sections of nor-
mal neonatal (A) and 
adult human skin (B) 
and CAL macules 
from NFl patients 
(C-D) were im-
munostained with 
anti - neuronbromin, 
and staining was vi-
sualized using perox-
idase immunohisto-
chemistry. A-C) 
Neuronbromin is 
present in both neo-
natal and adult skin 
and expression was 
maintained in nine of 
ten CAL macules. D) 
In one of ten CAL 
macules neuronbro-
min was greatly re-
duced or absent in 
keratinocytes but 
present in cells of the 
basal layer (probably 
melanocytes) . Arrow-
heads, melanocytes; 
arrows, macromelan-
osomcs. Scale bar, 20 
lim. 
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protein appeared most abundant at E21. Cl)'ost~t sections were iI7-
cubated with a radioactive 25 base synthetic ohgonucleotlde anti-
sense probe (Fig 3B) and adjacent sections incubated with a sense 
probe similarly synthesized (~ig 3C). A high den~ity of.neurofib.ro-
min mRNA is observed only m the suprabasal epidermiS followmg 
autoradiography. Keratinocytes are thus enriched in NF1 mRNA. 
The stratum germinatum and the underlying dermis contained no 
detectable mRNA; NF1 mRNA may be below the level of sensitiv-
ity of this assay. Because the suprabasal epidermis is . composed 
mainly of keratinocytes, we conclude that neurofibromm detected 
by immunocytochemistry is actually sythesized by the keratinocytes 
themselves. 
Distribution ofNeurofibromin in the Normal Human Epi-
dermis We compared the expression pattern of neurofibromin in 
the ra.t epidermis to that in .huI?an epidermis usinl? immunohisto-
chemistry. Neonatal foreskm tissue (n = 2) and skm samples from 
adult abdomin and scalp (n = 3) were studied. In neonatal skin (Fig 
4A), neurofibromin expression was identical to that observed in the 
perinatal rat. This pattern of expression was maintained. in. the adult 
human, in contrast to the adult rat, where neurofibromm Immuno-
reactivity is not detectable (Fig 4B). 
Analysis of Neurofibromin Expression in Cafe-au-Lait and 
Non-Cafe-au-Lait Tissue The distribution of neurofibromm 
in the skin of NFl patients was analyzed by immunohistochemisty 
in CALM and adjacent normally pigmented skin (n = 10). In nine of 
ten paired samples, the normal human pattern of neurofibromin 
expression was observed (Fig 4C). In one CALM, we were unable ~o 
detect neurofibromin in keratinocytes (Fig 4D). Neurofibromm 
was also undetectable in keratinocytes in normally pigmented skin 
adjacent to this CALM. A transition to normalneurofibromin levels 
was visible 2 mm away from the lesion (Fig SA). Keratinocytes that 
appear to contain an intermediate level of neurofi~)fomin im~uno­
reactivity present at the border between keratmocytes Without 
neurofibromin and those with normal levels of neurofibromin are 
likely to reflect tangential cuts through an abrupt border region. In 
all CALM evaluated macromelanosomes were present both in kera-
tinocytes and melanocytes (Fig 4C,D), confirming previous studies 
[12-15]. Macromelanosomes were also present in normally pig-
mented skin adjacent to CALMs. 
Neurofibr{)min Expression in Keratinocytes and Melano-
cytes Cells in the basal layer were stained by anti-neurofibromin 
antibodies in all human skin specimens analyzed (Figs 4A,B,D and 
SB,C). As melanocytes are present in this layer, we performed fluo-
rescence immunohistochemistry double labeling with a melano-
cyte-specific antibody (TA99) [27]. In the normal neonate (not 
shown) and normal adult (Fig 6A,B), melanocytes express neurofi-
bromin as T A99-positive cells were double labeled by anti-neurofi-
bromin antibody. Neurofibromin was also detectable in melano-
cytes from CALM (Fig 6C-D). 
DISCUSSION 
A key finding of this study is that neurofibromin expression in the 
epidermis is maintained in the adult human, whereas it is expressed 
only transiently in the rat skin. The finding that neurofibromin is 
expressed only in the perinatal period in the rat may be explained by 
the fact that, once the rat develops fur and perinatal hyperplasia of 
the epidermis regresses, the rat no longer resembles the human state 
[33]. In contrast, the nervous system displays similar or identical 
neurofibromin distribution in the rodent and the human [17]. 
We detected neurofibromin in both keratinocytes and melano-
cytes in normal adult human skin. As shown for the nervous system 
[17], neurofibromin expression in the epidermis is not restricted to 
neural crest derivatives . Because melanocytes transfer melanin via 
dendrites to surrounding keratinocytes [35], it was possible that 
neurofibromin detected in keratinocytes was produced by melano-
cytes, and transferred to keratinocytes. To test this, we used in situ 
hybridization to demonstrate that NF1 mRNA is present in kerati-
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Figure 5. Immunofluorescence distribution of neurofibromin in normally 
pigmented skin adjacent to a CAL macule. Cryostat sections of the CALM 
shown in Fig 4D were labeled by flourescence immunohistochemistry using 
anti-neurofibromin. A) The transition from low to high neurofibromin in 
keratinocytes is shown in A; on the left side of A keratinocytes are brightly 
stained by anti-neurofibromin whereas on the right keratinocytes are not 
detectably labeled. Scale bar, 40 J.Lm. Band C show normal and low neurofi-
bromin regions at higher magnification. Arrowheads, cells in the basal layer, 
probably mclanocytes, that are neurofibromin-positive even when keratino-
cytes are unstained. Scale bar, 40 J.Lm. 
nocytes. Thus, neurofibromin is enriched in ectodermal derivatives, 
including but not restricted to neural crest-derived cells. 
N eurofibromin is expressed at a low level in basal keratinocytes, is 
most enriched in spinous keratinocytes, and is undetectable in the 
metabolically inactive cells of the s. corneum. Our data suggest that 
neurofibromin is expressed at a low level in the stem cells of the 
epidermis (the basal cells) [36]' increases as cells differentiate, then 
ceases abruptly at terminal differentiation. Low levels of neuron-
bromin in basal cells appeared to be uniformly distributed, whereas 
neurofibromin was associated with the plasma membrane in supra-
basal keratinocytes. It is possible that keratinocytes translocate neur-
ofibromin from the cytosol to the plasma membrane when basal 
cells are stimulated to differentiate, then down-regulate neurofibro-
VOL. 102, NO.5 MAY 1994 
min expression upon terminal differentiation. The well-character-
ized modulator of ras, pI2°GAP, which has an extensive region of 
homology to neurofibromin, translocates to the membrane in cul-
tured primary mouse keratinocytes during calcium-induced kerati-
nocyte differentiation in vitro [37]. 
Ultrastructural analysis of neurofibromin showed localization to 
regions of the keratinocyte plasma membrane adjacent to desmo-
somes. While the function of neurofibromin in keratinocyte differ-
entiation remains to be determined, the pattern of localization is 
consistent with role(s) in this specialized domain of the plasma 
membrane. The finding that neurofibromin is enriched at the kerat-
inocyte plasma membrane is also consistent with the possibiliry that 
neurofibromin interacts with Ras. Ras may playa role ill keratino-
cyte differentiation as infection of cultured neonatal mouse kerati-
nocytes with activated ras retards keratinocyte differentiation in a 
model system [38 - 40]. It should be noted, however, that neurofi-
bromin, a large protein, may also interact with G-proteins other 
than Ras or with non-G-proteins. 
Evaluation of neurofibromin in CALM and unaffected skin from 
NFl patients was carried out to determine if alterations in amount 
or distribution of neurofibromin were evident. Neurofibromin im-
munoreactivity was detectable in melanocytes of all NFl biopsies, 
and in keratinocytes in nine of ten biopsies evaluated, at similar 
levels in NFl patients and normal human controls using two anti-
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Figure 6. Melano-
cytes express neurofi-
bromin in normal 
skin and NFl CAL 
macules. Cryostat 
sections were double 
labeled by fluores-
cence immunohisto-
chemistry with anti-
neurofibromin (A,C) 
and TA99 (B,D). A 
and B show a section 
from normal adult 
human skin; C and D 
show a section from 
a CALM. Arrows, 
TA99+ melanocytes 
that are also stained 
by anti-neurofibro-
min. Scale bar, 40 tLm. 
bodies recognizing widely separated domains of the protein. Be-
cause all NFl patiellts have a mutation in one NF1 gene, we had 
expected that less neurofibromin would be present in all neurofi-
bromin-expressing cells in these patients. To the contrary, we found 
that mutations at the NF1 locus do not cause a reduction in amount 
of detectable neurofibromin. In mice in which the NF1 gene is 
knocked out by homologous recombination, we were able to iden-
tify heterozygous mice by reduction in neurofibromin in tissue sec-
tions (Bra1111an et ai, submitted) with the same antibodies utilized in 
this study. It is possible that immunostaining methods used here are 
not sensitive enough to detect changes in neurofibromin levels in 
the human, or that many human NF1 mutations lead not to loss of 
neurofibromin, but rather to inactivation of some function of the 
protein. It is also possible that in humans NF1 message expression is 
regulated so that steady-state levels are normal even if one allele is 
non-functional. Our results strongly suggest that neurofibromin 
expression in the skin cannot, in most NFl patients, be used to 
distinguish NFl patients from normal humans; nor can neurofibro-
min expression be used to distinguish hyperpigmented NFl skin 
from normal skin. 
Although in most CALM neurofibromin levels and distribution 
was normal in keratinocytes as well as melanocytes, in one of ten 
skin biopsies neurofibromin was not detected in keratinocytes. This 
loss of neurofibromin in keratinocytes from an NFl CALM is the 
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first documentation of such loss in cells in a benign lesion of NFl, 
although several groups have reported loss of neurofibromin or 
inactivation of the NF1 gene in tumors [41-46]. We do not know if 
loss of neurofibromin is characteristic of all CALM from this pa-
tient, or if such a loss will be detectable in other patients. It is 
possible that there are patches of skin .that do .not show neuro~bro­
min expression in non-CALM-assoClated ski~ . Our ~a~ple ~lZ~ at 
present is too small to detect such patterns with statistical slgrufi-
cance. 
Based on the localization of neurofibromin to keratinocytes and 
melanocytes of the epidermis, it is clear that aberrant NF1 gene 
expression could have profound effects on skin functi<:>n .. With t~e 
identification of the cell types that express neurofirom111111 the Sk111 
and the identification of a developmental window in the rodent that 
parallels neurofibromin distribution in the human, it should be pos-
sible to perturb expression of neurofibromin in melanocytes and 
keratinocytes and test for cellular abnormalites predicted by pa-
tients' disease manefestations. 
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